Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
21.22
+1.79 (9.21%)
Aug 7, 2025, 4:00 PM - Market closed
Accolade Market Cap
Assembly Biosciences has a market cap or net worth of $162.81 million as of August 7, 2025. Its market cap has increased by 96.39% in one year.
Market Cap
162.81M
Enterprise Value
90.71M
1-Year Change
96.39%
Ranking
Category
Stock Price
$21.22
Market Cap Chart
Since December 17, 2010, Assembly Biosciences's market cap has increased from $40.20M to $162.81M, an increase of 304.99%. That is a compound annual growth rate of 10.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 6, 2025 | 149.10M | 48.65% |
Dec 31, 2024 | 100.30M | 86.09% |
Dec 29, 2023 | 53.90M | -14.98% |
Dec 30, 2022 | 63.40M | -43.14% |
Dec 31, 2021 | 111.50M | -44.19% |
Dec 31, 2020 | 199.80M | -62.51% |
Dec 31, 2019 | 532.90M | -7.48% |
Dec 31, 2018 | 576.00M | -26.83% |
Dec 29, 2017 | 787.20M | 276.11% |
Dec 30, 2016 | 209.30M | 61.75% |
Dec 31, 2015 | 129.40M | 54.60% |
Dec 31, 2014 | 83.70M | 5.02% |
Dec 31, 2013 | 79.70M | 185.66% |
Dec 31, 2012 | 27.90M | -71.93% |
Dec 30, 2011 | 99.40M | 135.55% |
Dec 31, 2010 | 42.20M | 4.98% |
Dec 17, 2010 | 40.20M | - |
View and export this data all the way back to 2010. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 575.32B |
Johnson & Johnson | 413.10B |
AbbVie | 351.30B |
Abbott Laboratories | 229.85B |
AstraZeneca | 227.78B |
Novartis AG | 223.01B |
UnitedHealth Group | 221.95B |
Novo Nordisk | 213.92B |